Showing 1 - 20 results of 75 for search 'Thomas Skripuletz', query time: 0.08s
Refine Results
-
1
Editorial: Autoimmune complications of modern cancer therapies by Nora Möhn, Nora Möhn, Mirjam Renovanz, Mirjam Renovanz, David Hagin, Thomas Skripuletz, Thomas Skripuletz
Published 2024-01-01
Article -
2
-
3
Role of CD20+ T cells in multiple sclerosis: implications for treatment with ocrelizumab by Stefan Gingele, Thomas Skripuletz, Roland Jacobs
Published 2020-01-01
Article -
4
The choline pathway as a strategy to promote central nervous system (CNS) remyelination by Thomas Skripuletz, Ralf A Linker, Martin Stangel
Published 2015-01-01
Article -
5
-
6
CDP-choline to promote remyelination in multiple sclerosis: the need for a clinical trial by Viktoria Gudi, Paweł Grieb, Ralf A Linker, Thomas Skripuletz
Published 2023-01-01
Article -
7
-
8
Multiple Levels of Control Processes for Wisconsin Card Sorts: An Observational Study by Bruno Kopp, Alexander Steinke, Malte Bertram, Thomas Skripuletz, Florian Lange
Published 2019-06-01
Article -
9
A comparative cross-sectional study of psychological distress, fatigue, and physical activity in patients with rheumatoid arthritis, systemic lupus erythematosus, and Sjögren's dis... by Sonja Beider, Michael Stephan, Tabea Seeliger, Thomas Skripuletz, Torsten Witte, Diana Ernst
Published 2025-01-01
Article -
10
-
11
-
12
-
13
Alzheimer’s disease biomarkers in cerebrospinal fluid are stable with the Elecsys immunoassay to most pre-analytical influencing factors except freezing at -80 °C by Franz Felix Konen, Hannah Benedictine Maier, Alexandra Neyazi, Stefan Bleich, Konstantin Neumann, Thomas Skripuletz
Published 2023-06-01
Article -
14
Targeted metabolomics identifies accurate CSF metabolite biomarkers for the differentiation between COVID-19 with neurological involvement and CNS infections with neurotropic viral... by Frieder Neu, Sandra Nay, Sven Schuchardt, Frank Klawonn, Thomas Skripuletz, Kurt-Wolfram Suehs, Frank Pessler
Published 2024-07-01
Article -
15
-
16
-
17
Disease-modifying therapies for relapsing/active secondary progressive multiple sclerosis – a review of population-specific evidence from randomized clinical trials by Antonios Bayas, Monika Christ, Simon Faissner, Juliane Klehmet, Refik Pul, Thomas Skripuletz, Sven G. Meuth
Published 2023-01-01
Article -
18
-
19
-
20